GPCR CIK: 1888886

Structure Therapeutics Inc.

  • United States
  • Healthcare
  • Biotech
Metrics score locked — part of Premium
FY21
FY22
FY23
FY24
FY25
FY21 – FY25
(positive)
millions USD
FY21:
–
FY22:
–
FY23:
–
FY24:
–
FY25:
0
(positive)
Change from FY22 to FY25
millions USD
FY21:
–
FY22:
−52.6
FY23:
−103
FY24:
−158
FY25:
−177
(positive)
Change from FY21 to FY24
millions USD
FY21:
−37.6
FY22:
−52.3
FY23:
−102
FY24:
−157
FY25:
–
(positive)
Change from FY21 to FY25
millions USD
FY21:
−37.8
FY22:
−51.3
FY23:
−89.4
FY24:
−122
FY25:
−141
(positive)
Change from FY21 to FY25
millions USD
FY21:
−40.0
FY22:
−51.3
FY23:
−89.6
FY24:
−123
FY25:
−141

All amounts in millions USD FY21: figures supplemented from Twelve Data because the SEC filings do not reach back this far. Data sources:SEC EDGARTwelve Data